1. Home
  2. JAGX vs CNFR Comparison

JAGX vs CNFR Comparison

Compare JAGX & CNFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • CNFR
  • Stock Information
  • Founded
  • JAGX 2013
  • CNFR 2009
  • Country
  • JAGX United States
  • CNFR United States
  • Employees
  • JAGX N/A
  • CNFR N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • CNFR Property-Casualty Insurers
  • Sector
  • JAGX Health Care
  • CNFR Finance
  • Exchange
  • JAGX Nasdaq
  • CNFR Nasdaq
  • Market Cap
  • JAGX 12.9M
  • CNFR 13.7M
  • IPO Year
  • JAGX N/A
  • CNFR 2015
  • Fundamental
  • Price
  • JAGX $0.86
  • CNFR $1.00
  • Analyst Decision
  • JAGX
  • CNFR
  • Analyst Count
  • JAGX 0
  • CNFR 0
  • Target Price
  • JAGX N/A
  • CNFR N/A
  • AVG Volume (30 Days)
  • JAGX 311.0K
  • CNFR 4.2K
  • Earning Date
  • JAGX 03-31-2025
  • CNFR 04-03-2025
  • Dividend Yield
  • JAGX N/A
  • CNFR N/A
  • EPS Growth
  • JAGX N/A
  • CNFR N/A
  • EPS
  • JAGX N/A
  • CNFR 2.40
  • Revenue
  • JAGX $10,480,000.00
  • CNFR $74,815,000.00
  • Revenue This Year
  • JAGX $18.18
  • CNFR N/A
  • Revenue Next Year
  • JAGX $40.06
  • CNFR $7.00
  • P/E Ratio
  • JAGX N/A
  • CNFR $0.41
  • Revenue Growth
  • JAGX N/A
  • CNFR N/A
  • 52 Week Low
  • JAGX $0.78
  • CNFR $0.65
  • 52 Week High
  • JAGX $21.60
  • CNFR $1.91
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 45.91
  • CNFR 45.41
  • Support Level
  • JAGX $0.78
  • CNFR $0.96
  • Resistance Level
  • JAGX $1.03
  • CNFR $1.07
  • Average True Range (ATR)
  • JAGX 0.07
  • CNFR 0.04
  • MACD
  • JAGX 0.01
  • CNFR 0.01
  • Stochastic Oscillator
  • JAGX 30.44
  • CNFR 47.78

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About CNFR Conifer Holdings Inc.

Conifer Holdings Inc is an insurance company engaged in the sale of property and casualty insurance products. It is engaged in three classes of insurance businesses namely commercial lines, personal lines, and wholesale agency business. Within these three businesses, the company offers various insurance products and insurance agency services. The company views the commercial and personal lines segments as underwriting business. The wholesale agency business provides non-risk bearing revenue through commissions and policy fees. Its revenues are derived from premiums earned from insurance operations.

Share on Social Networks: